Pharmaceutical Robots Market To Reach Size $458.4 Million by 2033

September 2026 | Report Format: Electronic (PDF)

Pharmaceutical Robots Market Growth & Trends

The global pharmaceutical robots market size is expected to reach USD 458.4 million by 2033, registering a CAGR of 8.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. Growth can be attributed to the surge in government initiatives and increase in healthcare spending on technological advancements. For instance, Japan’s Robot Strategy aims to establish the country as the premier hub for robot innovation globally. In 2022, the Japanese government provided over USD 930.5 million in support. This funding was distributed across various key sectors, such as manufacturing, nursing & medical, infrastructure, and agriculture.

Moreover, governments worldwide recognize these technological solutions have transformative potential in addressing healthcare challenges and improving patient outcomes. Hence, the rise in the number of government initiatives and healthcare spending is expected to propel the development and deployment of healthcare mobile robots. Furthermore, pharmaceutical companies prioritize more than just innovation to boost their patent portfolios. Some of the leading pharmaceutical companies are strategically investing in robotics to secure lucrative partnerships and position themselves at the forefront of industry advancements.

The need for automation in manufacturing facilities and the high costs of discovering new drugs are the other factors predicted to improve the demand for robotics in drug discovery, clinical trials, & laboratories. Hence, key companies have introduced technologically advanced robotic machines, propelling market growth. In addition, automation and robotics have gained immense popularity in the pharmaceutical industry due to the growing demand for precision, output, & faster turnaround times.

With the growing competition in the pharmaceutical industry, drug manufacturers are revolutionizing manufacturing processes with robotic technology. This technology has increased manufacturing efficiency and a growing ability to offer quality products at lower costs. These factors are expected to fuel the demand for pharmaceutical robots for manufacturing processes in the coming decade. Furthermore, key players are undertaking various strategies, such as mergers & acquisitions and collaborative agreements, facilitating market growth. For instance, in July 2023, ABB launched two new variants of its GoFa collaborative robot: The GoFa 10 and GoFa 12. These additions would provide companies with enhanced opportunities to utilize cobot automation, boosting efficiency.

key Request a free sample copy or view report summary: Pharmaceutical Robots Market Report

Pharmaceutical Robots Market Report Highlights

Based on product, the traditional robots segment dominated the market and accounted for the largest share of 62.4% in 2025. Benefits associated with adopting these products in various industrial automation applications include loading & unloading, pick & place material handling, palletizing & depalletizing, packaging, & storing.
Based on application, the picking and packaging segment dominated the market, accounting for the largest share of 55.2% in 2025, and is expected to grow at the fastest CAGR over the forecast period. Robots facilitate high precision & efficiency and help manage material handling challenges.
Based on end use, the pharmaceutical companies segment accounted for the largest market share of 68.0% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. The rising application of robotics in pharmaceutical manufacturing aids reproducibility and repeatability while reducing human errors.
The pharmaceutical robots market in the Asia Pacific dominated the market with the largest revenue share of 66.4% in 2025.